Shinichi Sato is the Chairman and CEO of Sysmex Inostics. Prior to this, he was Vice President of Project Management of Alliance, and Clinical Planning at Astex Pharmaceutical Inc., where he was responsible for the global oncology drug development strategy and go-to-market tactics involved in launching new initiatives and building and managing strategic partnerships.

Shinichi has over 30 years of experience in the pharma and diagnostics industries and specializes in post-merger integration. He also has an abundance of familiarity with global partnerships in the pharma industry and portfolio management in drug development.

Shinichi draws inspiration for what he does at Sysmex Inostics from the knowledge that, with every new diagnostic we successfully commercialize, there are potentially thousands of patients whose lives could be changed.